0.68 - 0.75
0.33 - 0.86
13.79M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.54%
Positive revenue growth while 0819.HK is negative. John Neff might see a notable competitive edge here.
-15.02%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-30.53%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-30.53%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
2.50%
Positive net income growth while 0819.HK is negative. John Neff might see a big relative performance advantage.
0.99%
Positive EPS growth while 0819.HK is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
-4.19%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
1.44%
Slight or no buybacks while 0819.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
7.00%
Slight or no buyback while 0819.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
39.94%
Positive OCF growth while 0819.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
37.76%
Positive FCF growth while 0819.HK is negative. John Neff would see a strong competitive edge in net cash generation.
247.66%
10Y revenue/share CAGR under 50% of 0819.HK's 802.47%. Michael Burry would suspect a lasting competitive disadvantage.
19.94%
5Y revenue/share CAGR under 50% of 0819.HK's 122.48%. Michael Burry would suspect a significant competitive gap or product weakness.
-10.19%
Negative 3Y CAGR while 0819.HK stands at 67.53%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-6520.63%
Negative 10Y OCF/share CAGR while 0819.HK stands at 602.12%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-394.38%
Negative 5Y OCF/share CAGR while 0819.HK is at 817.36%. Joel Greenblatt would question the firm’s operational model or cost structure.
-261.16%
Negative 3Y OCF/share CAGR while 0819.HK stands at 255.71%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
17.38%
Below 50% of 0819.HK's 235.91%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
27.23%
5Y net income/share CAGR 1.25-1.5x 0819.HK's 19.85%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
59.09%
Below 50% of 0819.HK's 812.14%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
97.28%
5Y equity/share CAGR above 1.5x 0819.HK's 47.26%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
6.65%
Below 50% of 0819.HK's 32.72%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
578.71%
5Y dividend/share CAGR above 1.5x 0819.HK's 163.62%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
120.50%
Below 50% of 0819.HK's 502.17%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
44.39%
Our AR growth while 0819.HK is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-44.69%
Inventory is declining while 0819.HK stands at 1.11%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
14.57%
Asset growth 1.25-1.5x 0819.HK's 9.94%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
2.88%
Under 50% of 0819.HK's 6.26%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
206.46%
Debt growth far above 0819.HK's 62.83%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-36.19%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-4.02%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.